Lean Body

5-Amino-1MQ

NNMT Inhibitor for Fat Metabolism

Best For

Clients exploring non-incretin metabolic support, complementary protocols alongside GLP-1 agents

NNMT

Enzyme target overexpressed in fat tissue

Non-GLP-1

Independent mechanism of action

Available dose configurations

How It Works

5-Amino-1MQ inhibits nicotinamide N-methyltransferase (NNMT), an enzyme overexpressed in adipose tissue that promotes fat storage. Blocking NNMT shifts cellular metabolism toward energy expenditure and away from fat accumulation. This mechanism is entirely unrelated to the GLP-1 pathway, offering a complementary approach to metabolic support.

Key Research Areas

NNMT Inhibition

Directly targets the enzyme driving fat storage in adipose tissue

Metabolic Shift

Redirects cellular energy balance toward expenditure over accumulation

Novel Pathway

Works independently of incretin signaling — stackable with GLP-1 agents

Fat Metabolism

Reduces adipose tissue lipid storage capacity at the enzymatic level

Research Highlights

Entirely distinct from GLP-1 and amylin pathways — a new axis for metabolic support
Targets fat storage at the enzymatic level rather than appetite signaling

Formulation Notes

Common concentrations referenced in published clinical studies:

[5AM]5mg[50AM]50mg